Jonan Boto
Advertisement
Jonan Boto is a Director for Kin + Carta Advise.
Articles by Jonan Boto
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Industry Outlook 2026: Trends Transitioning from 2025 into 2026
2
Amgen Acquires UK Biotech Dark Blue Therapeutics
3
The Benefits of an Immune-Directed ADC Strategy
4
Personalized Medicine vs. Precision Medicine
5